Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Kelsen SG, Maurer M, Waters M, Dash A, et al. Respir Res 2025;26:302.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kelsen SG, Maurer M, Waters M, Dash A, et al. Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Respir Res 2025;26:302.
PMID: 41163220